Cytarabine Pfizer Stungulyf/innrennslislyf, lausn 100 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

cytarabine pfizer stungulyf/innrennslislyf, lausn 100 mg/ml

pfizer aps - cytarabinum inn - stungulyf/innrennslislyf, lausn - 100 mg/ml

Vyxeos liposomal (previously known as Vyxeos) الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

vyxeos liposomal (previously known as vyxeos)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - kyrningahvítblæði, mergbólga, bráð - Æxlishemjandi lyf - vyxeos liposomal er ætlað fyrir meðferð fullorðnir með nýlega greind, meðferð-tengjast bráð merg hvítblæði (t-aml) eða aml með mergmisþroski-breytingar (aml-yngri og yngri).

DepoCyte الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

depocyte

pacira limited - cýtarabín - meningeal æxli - Æxlishemjandi lyf - intrathecal meðferð á eitilæxlum heilahimnubólgu. Í meirihluta af sjúklingum slíka meðferð verður hluti af einkennum líknandi sjúkdómsins.

Vanflyta الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

vanflyta

daiichi sankyo europe gmbh - quizartinib dihydrochloride - kyrningahvítblæði, mergbólga - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Daurismo الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

daurismo

pfizer europe ma eeig - glasdegib maleate - kyrningahvítblæði, mergbólga, bráð - Æxlishemjandi lyf - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Doxorubicin medac Innrennslislyf, lausn 2 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

doxorubicin medac innrennslislyf, lausn 2 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - doxorubicinum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml

Fludarabin Actavis Stungulyfs-/innrennslisþykkni, lausn 25 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

fludarabin actavis stungulyfs-/innrennslisþykkni, lausn 25 mg/ml

actavis group ptc ehf. - fludarabinum fosfat - stungulyfs-/innrennslisþykkni, lausn - 25 mg/ml

Isovorin Stungulyf, lausn 10 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

isovorin stungulyf, lausn 10 mg/ml

pfizer aps (p) - calcii levofolinas inn - stungulyf, lausn - 10 mg/ml

Sendoxan Stungulyfsstofn, lausn 1 g أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 1 g

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g

Sendoxan Stungulyfsstofn, lausn 500 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 500 mg

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg